GRI Bio Inc (GRI)
0.4125
+0.01
(+2.94%)
USD |
NASDAQ |
May 16, 16:00
0.428
+0.02
(+3.76%)
After-Hours: 20:00
GRI Bio Shareholders Equity (Quarterly): 2.798M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.798M |
| December 31, 2023 | 0.259M |
| September 30, 2023 | 2.227M |
| Date | Value |
|---|---|
| June 30, 2023 | 4.038M |
| March 31, 2023 | 0.031M |
| December 31, 2022 | -1.625M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.625M
Minimum
Dec 2022
4.038M
Maximum
Jun 2023
1.288M
Average
1.243M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.587M |
| Total Liabilities (Quarterly) | 1.789M |